• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

早期非小细胞肺癌完全切除术后的复发预后

Prognosis of recurrence after complete resection in early-stage non-small cell lung cancer.

作者信息

Choi Pil Jo, Jeong Sang Seok, Yoon Sung Sil

机构信息

Department of Thoracic and Cardiovascular Surgery, Dong-A University College of Medicine, Korea.

出版信息

Korean J Thorac Cardiovasc Surg. 2013 Dec;46(6):449-56. doi: 10.5090/kjtcs.2013.46.6.449. Epub 2013 Dec 6.

DOI:10.5090/kjtcs.2013.46.6.449
PMID:24368972
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3868693/
Abstract

BACKGROUND

Tumor recurrence is the most common cause of treatment failure, even after complete resection of early-stage non-small cell lung cancer (NSCLC). In this study, we investigated the prognosis of patients with early recurrence in order to identify independent risk factors related to early recurrence.

METHODS

Between February 1995 and December 2012, 242 patients who underwent surgical resection for stage I NSCLC at Dong-A University Hospital were reviewed. The factors predicting overall survival (OS) and early recurrence were investigated. We also investigated the relationship between the patterns and period of recurrence and clinicopathological factors.

RESULTS

For patients with stage IA and IB NSCLC, the 5-year OS rate was 75.7% and 57.3% (p=0.006), respectively. A multivariate Cox proportional hazards model demonstrated that gender (p=0.004), comorbidity number (p=0.038), resection type (p=0.002), and tumor size (p=0.022) were the statistically significant predictors of OS. Moreover, the multivariate analysis revealed that smoking history (p=0.023) and histologic grade (p=0.012) were the independent predictors of early recurrence. Additionally, only histologic grade (poor differentiation) was found to be significantly associated with a higher frequency of distant metastasis; there was no relationship between the patterns and period of recurrence and clinicopathological factors.

CONCLUSION

The present study demonstrated that smoking history and histologic grade were independent prognostic factors for early recurrence within two years in patients with early-stage NSCLC. Patients with these predictive factors may be good candidates for adjuvant therapy.

摘要

背景

肿瘤复发是治疗失败的最常见原因,即使是早期非小细胞肺癌(NSCLC)完全切除术后也是如此。在本研究中,我们调查了早期复发患者的预后,以确定与早期复发相关的独立危险因素。

方法

回顾了1995年2月至2012年12月期间在东亚大学医院接受I期NSCLC手术切除的242例患者。研究了预测总生存期(OS)和早期复发的因素。我们还研究了复发模式和时期与临床病理因素之间的关系。

结果

对于IA期和IB期NSCLC患者,5年总生存率分别为75.7%和57.3%(p=0.006)。多变量Cox比例风险模型显示,性别(p=0.004)、合并症数量(p=0.038)、切除类型(p=0.002)和肿瘤大小(p=0.022)是OS的统计学显著预测因素。此外,多变量分析显示,吸烟史(p=0.023)和组织学分级(p=0.012)是早期复发的独立预测因素。此外,仅发现组织学分级(低分化)与远处转移频率较高显著相关;复发模式和时期与临床病理因素之间无相关性。

结论

本研究表明,吸烟史和组织学分级是早期NSCLC患者两年内早期复发的独立预后因素。具有这些预测因素的患者可能是辅助治疗的良好候选者。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e54a/3868693/26d5cffd00bd/kjtcs-46-449-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e54a/3868693/35cdaf5f9ec8/kjtcs-46-449-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e54a/3868693/26d5cffd00bd/kjtcs-46-449-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e54a/3868693/35cdaf5f9ec8/kjtcs-46-449-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e54a/3868693/26d5cffd00bd/kjtcs-46-449-g002.jpg

相似文献

1
Prognosis of recurrence after complete resection in early-stage non-small cell lung cancer.早期非小细胞肺癌完全切除术后的复发预后
Korean J Thorac Cardiovasc Surg. 2013 Dec;46(6):449-56. doi: 10.5090/kjtcs.2013.46.6.449. Epub 2013 Dec 6.
2
Stage I nonsmall cell lung cancer. A multivariate analysis of treatment methods and patterns of recurrence.I期非小细胞肺癌。治疗方法与复发模式的多变量分析。
Cancer. 1995 Sep 1;76(5):787-96. doi: 10.1002/1097-0142(19950901)76:5<787::aid-cncr2820760512>3.0.co;2-q.
3
Risk factor analysis of locoregional recurrence after sublobar resection in patients with clinical stage IA non-small cell lung cancer.临床ⅠA 期非小细胞肺癌亚肺叶切除术后局部区域复发的危险因素分析。
J Thorac Cardiovasc Surg. 2013 Aug;146(2):372-8. doi: 10.1016/j.jtcvs.2013.02.057.
4
Prognostic Impact of Multiple Clinicopathologic Risk Factors and c-MET Overexpression in Patients Who Have Undergone Resection of Stage IB Non-Small-Cell Lung Cancer.多临床病理危险因素及c-MET过表达对IB期非小细胞肺癌切除术后患者的预后影响
Clin Lung Cancer. 2016 Sep;17(5):e31-e43. doi: 10.1016/j.cllc.2016.01.005. Epub 2016 Feb 2.
5
Risk factors for both recurrence and survival in patients with pathological stage I non-small-cell lung cancer.Ⅰ期非小细胞肺癌患者的复发和生存的风险因素。
Eur J Cardiothorac Surg. 2013 Jul;44(1):e53-8. doi: 10.1093/ejcts/ezt192. Epub 2013 Apr 4.
6
Pathological vascular invasion and tumor differentiation predict cancer recurrence in stage IA non-small-cell lung cancer after complete surgical resection.完全手术切除后,病理性血管侵犯和肿瘤分化可预测 IA 期非小细胞肺癌的癌症复发。
J Thorac Oncol. 2012 Aug;7(8):1263-70. doi: 10.1097/JTO.0b013e31825cca6e.
7
Prognostic factors for lymph node negative stage I and IIA non-small cell lung cancer: multicenter experiences.淋巴结阴性的Ⅰ期和ⅡA期非小细胞肺癌的预后因素:多中心经验
Asian Pac J Cancer Prev. 2013;14(11):6287-92. doi: 10.7314/apjcp.2013.14.11.6287.
8
Early recurrence after surgical resection in patients with pathological stage I non-small cell lung cancer.病理分期为I期的非小细胞肺癌患者手术切除后的早期复发
Thorac Cardiovasc Surg. 2009 Dec;57(8):472-5. doi: 10.1055/s-0029-1185734.
9
Prognostic significance of histologic differentiation, carcinoembryonic antigen value, and lymphovascular invasion in stage I non-small cell lung cancer.组织学分化、癌胚抗原值及淋巴管浸润在Ⅰ期非小细胞肺癌中的预后意义
J Thorac Cardiovasc Surg. 2014 Oct;148(4):1200-1207.e3. doi: 10.1016/j.jtcvs.2014.04.038. Epub 2014 Apr 23.
10
Factors influencing recurrence following anatomic lung resection for clinical stage I non-small cell lung cancer.解剖性肺切除术治疗Ⅰ期非小细胞肺癌术后复发的影响因素。
Lung Cancer. 2019 Feb;128:145-151. doi: 10.1016/j.lungcan.2018.12.026. Epub 2018 Dec 26.

引用本文的文献

1
Prevalence of Mutations in Vietnamese Patients with Resected Early Stage Non-Small Cell Lung Cancer: EARLY-EGFR Study.越南早期非小细胞肺癌切除患者的突变患病率:EARLY-EGFR研究
Lung Cancer (Auckl). 2025 Apr 21;16:39-49. doi: 10.2147/LCTT.S494554. eCollection 2025.
2
Calcium Sulfide Nanoclusters Trigger DNA Damage and Induce Cell Cycle Arrest in Non-Small-Cell Lung Adenocarcinoma Cells.硫化钙纳米团簇引发非小细胞肺腺癌细胞的DNA损伤并诱导细胞周期停滞。
Int J Mol Sci. 2025 Feb 15;26(4):1665. doi: 10.3390/ijms26041665.
3
Prognostic potential of integrated morphologic and metabolic parameters of pre-therapeutic [18F]FDG-PET/CT regarding progression-free survival (PFS) and overall survival (OS) in NSCLC-patients.

本文引用的文献

1
Poor prognostic factors in patients with stage IB non-small cell lung cancer according to the seventh edition TNM classification.根据第七版 TNM 分类,IB 期非小细胞肺癌患者的预后不良因素。
Chest. 2011 Apr;139(4):855-861. doi: 10.1378/chest.10-1535. Epub 2010 Aug 19.
2
Recent advances in lung cancer: summary of presentations from the 45th annual meeting of the American Society of Clinical Oncology (2009).近年来肺癌领域的研究进展:第 45 届美国临床肿瘤学会年会(2009 年)演讲总结。
J Thorac Oncol. 2009 Oct;4(10):1293-300. doi: 10.1097/JTO.0b013e3181b7ef95.
3
Post-recurrence survival in completely resected stage I non-small cell lung cancer with local recurrence.
[18F]FDG-PET/CT 治疗前形态学和代谢综合参数对 NSCLC 患者无进展生存期(PFS)和总生存期(OS)的预后潜力。
PLoS One. 2024 Jul 29;19(7):e0307998. doi: 10.1371/journal.pone.0307998. eCollection 2024.
4
Prognostic factors in completely resected lymph-node-negative pulmonary adenocarcinoma.完全切除的淋巴结阴性肺腺癌的预后因素
Transl Cancer Res. 2022 Jul;11(7):2238-2248. doi: 10.21037/tcr-21-2633.
5
Anesthetic and analgesic techniques and perioperative inflammation may affect the timing of recurrence after complete resection for non-small-cell lung cancer.麻醉和镇痛技术以及围手术期炎症可能会影响非小细胞肺癌完全切除术后复发的时间。
Front Surg. 2022 Jul 26;9:886241. doi: 10.3389/fsurg.2022.886241. eCollection 2022.
6
Ground Glass Opacity and Adjuvant Chemotherapy in Pathological Stage IB-IIA Lung Adenocarcinoma.病理分期为IB-IIA期肺腺癌的磨玻璃影与辅助化疗
Front Oncol. 2022 Mar 25;12:851276. doi: 10.3389/fonc.2022.851276. eCollection 2022.
7
SUVmax to tumor perimeter distance: a robust radiomics prognostic biomarker in resectable non-small cell lung cancer patients.SUVmax 到肿瘤边界距离:可用于预测可切除非小细胞肺癌患者预后的稳健影像组学生物标志物。
Eur Radiol. 2022 Jun;32(6):3889-3902. doi: 10.1007/s00330-021-08523-3. Epub 2022 Feb 8.
8
Postoperative Adverse Events are Associated with Oncologic Recurrence Following Curative-intent Resection for Lung Cancer.术后不良事件与肺癌根治性切除术后的肿瘤复发相关。
Lung. 2020 Dec;198(6):973-981. doi: 10.1007/s00408-020-00395-6. Epub 2020 Oct 9.
9
Prognostic factors in operated T3 non-small cell lung cancer: A retrospective, single-center study of 129 patients.手术治疗的T3期非小细胞肺癌的预后因素:一项对129例患者的回顾性单中心研究。
Turk Gogus Kalp Damar Cerrahisi Derg. 2018 Jan 9;26(1):108-115. doi: 10.5606/tgkdc.dergisi.2018.14141. eCollection 2018 Jan.
10
Post surgery circulating free tumor DNA is a predictive biomarker for relapse of lung cancer.手术后循环游离肿瘤DNA是肺癌复发的预测生物标志物。
Cancer Med. 2017 May;6(5):962-974. doi: 10.1002/cam4.980. Epub 2017 Apr 5.
完全切除的Ⅰ期非小细胞肺癌局部复发后的复发后生存情况。
Thorax. 2009 Mar;64(3):192-6. doi: 10.1136/thx.2007.094912.
4
Postrecurrence survival in patients with stage I non-small cell lung cancer.I期非小细胞肺癌患者复发后的生存情况
Eur J Cardiothorac Surg. 2008 Sep;34(3):499-504. doi: 10.1016/j.ejcts.2008.05.016. Epub 2008 Jun 25.
5
Lung adjuvant cisplatin evaluation: a pooled analysis by the LACE Collaborative Group.肺癌辅助顺铂评估:LACE协作组的汇总分析
J Clin Oncol. 2008 Jul 20;26(21):3552-9. doi: 10.1200/JCO.2007.13.9030. Epub 2008 May 27.
6
A perspective on DNA microarrays in pathology research and practice.病理学研究与实践中DNA微阵列的前景
Am J Pathol. 2007 Aug;171(2):375-85. doi: 10.2353/ajpath.2007.070342. Epub 2007 Jun 28.
7
Survival after recurrent nonsmall-cell lung cancer after complete pulmonary resection.全肺切除术后复发性非小细胞肺癌的生存情况。
Ann Thorac Surg. 2007 Feb;83(2):409-17; discussioin 417-8. doi: 10.1016/j.athoracsur.2006.08.046.
8
Stage IB nonsmall cell lung cancers: are they all the same?IB期非小细胞肺癌:它们都一样吗?
Ann Thorac Surg. 2006 Jun;81(6):1958-62; discussion 1962. doi: 10.1016/j.athoracsur.2005.12.054.
9
Prognostic factors in non-small cell lung cancer: a decade of progress.非小细胞肺癌的预后因素:十年进展
Chest. 2002 Sep;122(3):1037-57. doi: 10.1378/chest.122.3.1037.
10
Stage I nonsmall cell lung carcinoma: analysis of survival and implications for screening.I期非小细胞肺癌:生存分析及对筛查的意义
Cancer. 2000 Dec 1;89(11 Suppl):2334-44. doi: 10.1002/1097-0142(20001201)89:11+<2334::aid-cncr4>3.3.co;2-9.